Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients

Therapeutic Apheresis and Dialysis

Volumn 13, Issue 4, 2009, Pages 268-272

  Pečovnik Balon, Breda ^a   Jakopin, Eva ^a   Bevc, Sebastjan ^a   Knehtl, Masa ^a   Gorenjak, Maksimiljan ^a  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

Author keywords

25 Hydroxyvitamin D; End stage renal disease; Hemodialysis; Mortality; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; PHOSPHATE;

ADULT; CALCIUM BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSIS, MEASUREMENT AND ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; VITAMIN D DEFICIENCY;

AGED; CALCIUM; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RENAL DIALYSIS; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 68849094295     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00722.x     Document Type: Conference Paper

References (18)

1. Taskapan H, Wei M. 25(OH) Vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol 2006 38 : 323 9.
2. Jones G. Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1α-hydoxylase in the classical and nonclassical actions of 1α,25-dihydroxyvitamin D3. Semin Dial 2007 20 : 316 24.
3. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune disease, cancers, and cardiovascular disease. Am J Clin Nutr 2004 80 (Suppl. S1678 88.
4. Wolf M, Shah A, Gutierrez O et al. Vitamin D levels and early mortality among incident hemodialysis patient. Kidney Int 2007 72 : 1004 13.
5. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003 42 : S1 201.
6. Hsia J, Heiss G, Ren H et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007 115 : 846 54.
7. Wang TJ, Pencina MJ, Booth SL et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008 117 : 503 11.
8. Gonzales EA, Sachdeva A, Oliver DA, Martin KJ. Vitamin D insufficiency and deficiency in chronic kidney disease. Am J Nephrol 2004 24 : 503 10.
9. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998 32 : S112 19.
10. Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008 168 : 1629 37.
11. Dobnig H, Pilz S, Scharnagl H. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008 168 (12 1340 9.
12. Jacob AI, Sallman A, Santiz Z et al. Defective photoproduction of cholecalciferol in normal in uremic humans. J Nutr 1984 114 : 1313 19.
13. Jean G, Charra B, Chazot C. Vitamin D deficiency and associated factors in hemodialysis patients. J Ren Nutr 2008 18 : 395 9.
14. Schiffrin EL, Lipman ML, Mann JFE. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007 116 : 85 97.
15. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005 289 : F8 28.
16. Tokmak F, Quack I, Schieren G et al. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant 2008 23 : 4016 20.
17. Jean G, Terrat JC, Vanel T et al. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant 2008 23 : 3670 6.
18. Saab G, Young DO, Gincherman Y et al. Deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract 2007 105 : 132 8.